baber/WOPTO huggingface dataset:
Patent AU-3314400-A (AU)
Title: Amino group containing support matrices, their use and manufacture
Inventor: FONNUM GEIR
IPC: C08G81/02
Filed: 2000-03-22
Abstract: A method for the manufacture of a support matrix exhibiting amino groups I, possibly in acylated form, comprising the step of polymerising one or more monovinyl monomers (monomer I) with one or more di- tri- or polyvinyl monomers (monomer II). The method is characterized in that that the polymerisation is run in the presence of one or more amino-(C0-10)hydrocarbon vinyl aromatic monomers possibly in acylated form (monomer III. <??>The preferred combination of monomers are ethyl vinyl benzene, divinyl benzene and amino styrene. <??>A support matrix comprising a polyvinyl backbone Ä(-CH2CH2)nÜ and amino groups or groups derived from said amino groups while retaining the nitrogen of the amino group, each of which groups being attached to said backbone via a link structure containing an arylene group. The matrix is charactetized in that each of said groups is directly attached via said nitrogen to said arylene group. <??>The use of the support matrix as defined in any one of claims 1-17, for solid phase synthesis, for instance of an oligo/poly-nucleotide or an oligo/polypeptide.
Patent AU-3346399-A (AU)
Title: Concrete pile and method for positioning it in the ground
Inventor: TOORENMAN LAMBERTUS ROELOF
IPC: E02D9/00
Filed: 1999-04-08
Abstract: Concrete pile (1) for supporting structures a certain distance above ground level (M), such as viaducts and the like. The pile is characterized in that it is entirely prefabricated and comprises a hollow cylindrical shaft (2), which contains an upper pier section (2a) and a foundation section (2b). The foundation section has an oppen bottom end (3) and is in its area which adjoins the said open end provided with an external screw thread (4, 5), for screwing said pile in the ground. The shaft of said pile containing a number of ducts (20), which are distributed over the circumference, which ducts open out on the outside of the shaft in the area of the external screw thread. The invention also relates to a method for positioning said pile in the ground, said method being characterized in that while the pile is being screwed in, a liquid medium is injected on its outside via the ducts (20) and the position of the pile while it is being screwed in is controlled by varying locally along the external circumference of the pile, the volume and/or pressure of the supplied liquid medium.
Patent AU-3487497-A (AU)
Title: A method for diagnosis and prognosis of cancer
Inventor: ZETTER BRUCE R
IPC: C12Q1/68
Filed: 1997-06-13
Abstract: The present inventors have discovered that humans have a gene that encodes a novel protein of the thymosin  beta  family. This novel protein, herein referred to as thymosin  beta 15, has the ability to bind and sequester G-actin, like other members of the thymosin  beta  family, but unlike what is known about other members also directly regulates cell motility in prostatic carcinoma cells. A cDNA of the human thymosin  beta 15 gene (SEQ ID NO: 1) and having deduced the amino acid sequence (SEQ ID NO: 2) was isolated. The present inventors have shown that the enhanced transcripts (mRNA) and expression of the thymosin  beta 15 gene in non-testicular cells has a high correlation to disease state in a number of cancers, such as prostate, lung, melanoma and breast cancer, particularly metastatic cancers. Accordingly, discovering enhanced levels of transcript or gene product in non-testicular tissues can be used in not only a diagnostic manner, but a prognostic manner for particular cancers. <IMAGE>
Patent AU-3531695-A (AU)
Title: Encoding and decoding of a wideband digital information signal
Inventor: KERKHOF LEON MARIA VAN DE
IPC: H04B14/00
Filed: 1995-10-06
Abstract: An encoder apparatus is disclosed for encoding a wideband digital information signal. The apparatus comprises an input signal (1) for receiving the wideband digital information signal, a signal splitting unit (2) for splitting the wideband digital information signal into M narrow band sub signals (SB1 to SBM). The narrow bands all have a specific constant bandwidth. Further, a scale factor determining unit (6) for determining a scale factor for subsequent signal blocks in each of the sub signals, and a quantization unit (13) for quantizing the samples in a signal block into quantized samples are present. A bit allocation information deriving unit (34,41,48) is present for deriving bit allocation information, the bit allocation information being representative of the number of bits with which samples in a signal block of a sub signal will be represented after quantization in the quantization unit (13). A formatting unit (20) is present for combining the quantized samples in the signal blocks of the quantized sub signals and the scale factors into a digital output signal having a format suitable for transmission or storage. The apparatus further comprises a signal block length determining unit (30) for determining the lengths of the signal block in at least one of the sub signals and for generating block length information, the block length information being representative of the said lengths of the signal blocks of the said at least one sub signal, where the lengths of subsequent signal blocks in said at least one sub signal differ. The scale factor determining unit (6) now determines the scale factors for subsequent signal blocks of varying lengths in response to said block length information, the bit allocation information deriving unit (34,41,48) now derives bit allocation information for subsequent signal blocks of varying lengths in response to said block length information, and the quantization unit (13) now quantize the samples in signal blocks of varying lengths in response to said block length information. The formatting unit (20) further includes the block length information into the digital output signal for transmission or storage.
Patent AU-3564399-A (AU)
Title: System for reliable prevention of the restarting of a machine
Inventor: HOVINE CLAUDE
IPC: H02H11/00
Filed: 1999-04-15
Abstract: A safety lock out switch system for the prevention of an unexpected restart of an electrically powered machine in whose main power circuit it is installed. Therein the power-free status of the power supply output of the system is confirmed visually. The system is configured so it is flexible, thus being able to be used in the most various types or sizes of machines. Technical aspects andsafety aspects were taken into account therein so that the installation can be carried out in practically every country in the world.
Patent AU-3737293-A (AU)
Title: Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
Inventor: ROSEBROUGH SCOTT F
IPC: A61K51/10
Filed: 1993-03-03
Abstract: The present invention provides biotinylated compounds useful for delivering a molecule to a target site, and methods of making biotinylated compounds. The biotinylated compounds are covalent conjugates of biotin and a diagnostic or therapeutic agent, and are stable to rapid degradation by biotinidase. The compounds of the invention are useful for delivering therapeutic or diagnostic agents to target-bound streptavidin or avidin conjugated cell-targeting agents, including monoclonal antibodies. The compound N-cysteinyl biotin is also provided.
Patent AU-4110993-A (AU)
Title: Methods of treating cancer using modified C-reactive protein
Inventor: POTEMPA LAWRENCE A
IPC: A61P35/00
Filed: 1993-04-22
Abstract: The invention provides a method of treating cancer in a mammal comprising administering to the mammal an effective amount of modified C-reactive protein ("mCRP"). The invention also provides a method of treating cancer in a mammal comprising administering to the mammal mCRP in combination with another agent such as a chemotherapeutic compound, immunoadjuvant, or cytokine. The mCRP may be administered to the mammal in a pharmaceutically-acceptable carrier or in liposomes. The invention further provides a method of identifying cancer cells in a mammal using mCRP as an imaging agent.
Patent AU-4269699-A (AU)
Title: Ornamental chain consisting of successive elements each having a general spherical shape
Inventor: GOMEZ LUIS
IPC: A44C11/00
Filed: 1999-06-18
Abstract: An ornamental chain made up of successive elements, in which at least one of said elements includes a hollow body inside which an insert is fixed that is designed to retain a link member that is linked to an adjacent element of the chain, said insert being constituted by at least one sleeve. The sleeve includes a slot that is wide enough to enable the shank of the link member to pass therethrough.
Patent AU-4319793-A (AU)
Title: Process and device for a microcellular common-channel radio system
Inventor: SCHMIDT WERNER DR ING
IPC: H04Q7/20
Filed: 1993-05-29
Abstract: The description relates to a process for improving radio reception on a road system consisting of individual traffic lanes intersecting at any  angle via a cellular mobile radio system which comprises a number of adjacent and mutually contacting or partially overlapping radio cells. In the boundary region of each cell there is at least one fixed transmitter with at least one sector aerial which covers at least part of a region of this cell to be supplied with radio frequencies of a channel group. At least one further fixed transmitter is arranged in the transition region with an immediately adjacent cell and at this post there is at least one sector aerial providing the cell to be supplied itself with the same channel group as the fixed transmitter, two or more fixed transmitters transmit simultaneously to a cell and the cells in a linear road structure have a star structure consisting of mutually overlapping ellipsoidal partial areas.
Patent AU-4506085-A (AU)
Title: Fat containing diglycerides
IPC: A23C15/14
Filed: 1985-07-16
Abstract: Edible fat compositions containing diglycerides or a mixture of diglycerides and monoglycerides, wherein (i) the amount of diglycerides ranges from 5-30 %, (ii) the level of saturated C<sub>16</sub>- to C<sub>22</sub>-fatty acid residues in said diglycerides does not exceed 45 % and (iii) the ratio of diglyceride to saturated monoglyceride exceeds 8:1 and the ratio of diglyceride to unsaturated monoglyceride exceeds 5:1.Emulsions prepared from such compositions display butterlikeness and improved spreadability.
Patent AU-4535485-A (AU)
Title: Process for controlling snout zinc vapor in a hot dip zinc based coating on a ferrous base metal strip
Inventor: BOSTON STEVEN L
IPC: C23C2/02
Filed: 1985-07-25
Abstract: A process for suppressing zinc vapor in the snout of a continuous line for hot dip coating one side or both sides of a ferrous base metal strip with a molten zinc or zinc based alloy by maintaining the atmosphere within the snout to include about 1-8% hydrogen by volume and about 300 ppm to 4500 ppm water vapor with the balance being one or more inert gases, such as nitrogen. The atmosphere has a hydrogen/water vapor ratio of at least 4 to 1, or higher. This atmosphere is oxidizing to zinc vapor but non-oxidizing to the ferrous strip.
Patent AU-4666989-A (AU)
Title: Circuit for reversing a magnetic field
Inventor: ZUCKER FRIEDHELM
IPC: H03K17/04
Filed: 1989-11-17
Abstract: PCT No. PCT/EP89/01391 Sec. 371 Date Jun. 17, 1991 Sec. 102(e) Date Jun. 17, 1991 PCT Filed Nov. 17, 1989 PCT Pub. No. WO90/05980 PCT Pub. Date May 31, 1990.A circuit arrangement for reversing a magnetic field, in which an oscillator has a coil connected in parallel with a capacitor. First and second diodes are connected oppositely-poled in a series circuit, which is connected in parallel with the coil and capacitor of said oscillator. A first electronic controlled switch is connected in parallel with the first diode for bypassing this diode, whereas a second electronic controlled switch is connected in parallel with the second diode for bypassing thereof. Energy is supplied to the oscillator whenever the capacitor discharges. The junction of the series connected diodes is connected to the junction of the series-connected switches.
Patent AU-4748693-A (AU)
Title: Metal/air cell for a battery
Inventor: O'CALLAGHAN WILFRID BERNARD
IPC: H01M50/77
Filed: 1993-09-20
Abstract: A metal-air battery is described having recirculated electrolyte. The battery comprises:     (a) a tank (10) defining a reservoir for liquid electrolyte, (b) a support panel (11) mounted in the tank above the electrolyte reservoir; (c) a plurality of individually removable metal-air cells (12) mounted in side-by-side relationship on said support panel (11) with air gaps therebetween, each cell comprising a pair of spaced-apart flat side walls (21) joined by end faces and top and bottom faces, said side walls including air cathodes (22), a metal anode (26) mounted between and spaced from said flat side walls, an electrolyte inlet connector below the lower edge of the anode and an electrolyte outlet connector, said connectors being adapted to removably extend through openings in said support panel, and said outlet connector being adapted to return electrolyte to the reservoir; and   (d) circuit means for connecting said cells to an external load. u
Patent AU-4757696-A (AU)
Title: Taste masking liquids
Inventor: POPLI SHANKAR DASS
IPC: A61K9/00
Filed: 1996-01-16
Abstract: There is provided a pharmaceutically acceptable taste masking liquid excipient base for administration of relatively large amounts of unpleasant tasting medicines, said excipient base having higher than normal viscosities due to a combination of polyethylene glycol and cellulosic material.
Patent AU-5277599-A (AU)
Title: Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
Inventor: HUBLER DORIS
IPC: B66C23/86
Filed: 1999-06-07
Abstract: This invention relates to pharmaceutical combinations for compensating for an absolute and relative testosterone deficiency in men with simultaneous prophylaxis for the development of a benign prostatic hyperplasia (BPH) or prostate cancer. The combinations according to the invention contain a natural or synthetic androgen in combination with a gestagen, an antigestagen, an antiestrogen, a GnRH analog, a testosterone-5alpha-reductase inhibitor, an alpha-andreno-receptor blocker or a phosphodiesterase inhibitor. In comparison to the combinations according to the invention, any active ingredient by itself cannot achieve the desired goal.
Patent AU-5535994-A (AU)
Title: A method for the manufacturing of an absorbent structure and an absorbent article for blood absorption comprising an absorbent structure manufactured according to this method
Inventor: WIDLUND URBAN
IPC: A61F13/20
Filed: 1993-11-15
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent AU-5559900-A (AU)
Title: Laser cutting system
Inventor: ULRICH JOHANNES
IPC: B23Q1/01
Filed: 2000-07-14
Abstract: A laser cutting system has a specially designed frame (2) that allows the laser cutting head to be mounted to the underside of a cross beam (4) for a more efficient movement. The frame (2) is further designed so as to allow the accessing of the work area of the laser cutting system along three different directions. The movement of the laser cutting head for fabricating a sheet placed in the work area of the laser cutting system is effected by a process that takes into consideration a number of parameters and determined data all of which are interpolated for generating optimal movements to further enhance the operating efficiency of the laser cutting system. The laser resonator of the laser cutting system of the instant invention is configured to have a telescopic system (88) that maintains the density and power of the laser beam by auto focusing the same so that optimum cuts can be effected irrespective of whichever area of the worksheet is to be fabricated. A special design worktable in the working area of the laser cutting system provides support for the worksheet.
Patent AU-5773500-A (AU)
Title: Inhibitors of memapsin 2 and use thereof
Inventor: TANG JORDAN J N
IPC: C12N9/99
Filed: 2000-06-27
Abstract: Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bond to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
Patent AU-5786790-A (AU)
Title: (alpha-(tert.butyl aminomethyl)-3,4-dichlorobenzyl) thioacetamide, a procedure for its preparation and its uses
Inventor: LAFON LOUIS
IPC: A23K1/16
Filed: 1990-06-26
Abstract: [ alpha -(tert-Butylaminomethyl)-3,4-dichlorobenzyl]thioacetamide of formula: <IMAGE>  and its addition salts with pharmaceutically acceptable acids. These compounds can be employed as antidepressants and for promoting food intake.
Patent AU-5869386-A (AU)
Title: Method and apparatus for creating encrypted and decrypted television signals
Inventor: LUCAS JOHN D LOWRY KEITH
IPC: H04N7/169
Filed: 1986-04-17
Abstract: A method and apparatus for creating a television signal and encrypting or decrypting the signal at the same time. Luminance and chrominance information are received by the apparatus and stored in separate television scan line stores. The stored liminance and chrominance information is read out from their respective stores at a frequency corresponding to a desired format or standard to create the television signal. The signal may be simultaneously encrypted or decrypted by delaying the time at which the luminance and/or chrominance information is read out in accordance with an encryption or decryption key.
Patent AU-5949194-A (AU)
Title: Inverse discrete cosine transform processor
Inventor: HOOGENBOOM CHRISTOPHER L
IPC: H03M7/30
Filed: 1994-04-15
Abstract: A method and apparatus (10) are provided for inverse transforming a matrix of discrete cosine transform (DCT) coefficients. The DCT coefficients are processed at least two bits at a time to obtain the vector dot products thereof with a DCT kernel matrix. A matrix of the vector dot products is transposed (112) to obtain a transposed matrix of dot product elements. The dot product elements of the transposed matrix are processed at least two bits at a time to obtain the vector dot products thereof with the DCT kernel matrix. The resultant dot products are interleaved into a proper order and buffered in a series of output registers (118). Further efficiencies are achieved by implementing a post-add stage (104) of an IDCT flowgraph prior to the output registers. <IMAGE>
Patent AU-6088499-A (AU)
Title: Method for generating a three-dimensionally viewable film sequence from a film
Inventor: WIEDENMANN HENRIKE DOROTHEA
IPC: H04N13/221
Filed: 1999-10-01
Abstract: The invention relates to a method for generating a three-dimensionally viewable film sequence (3D-film sequence) from a film comprising several sequentially arranged single pictures intended for two-dimensional viewing. Excerpts of the film are selected taking into consideration pre-defined selection criteria and the selected excerpts are mixed to produce a 3D-film sequence. A minimum selection criterion is at least provided in such a way that individual pictures pertaining to an excerpt have at least two reference objects which are each located in different viewing planes situated within a viewing space and exhibit a relative movement parallel to each other in an essentially horizontal direction within said excerpt.
Patent AU-6149094-A (AU)
Title: Amide derivatives as 5-ht1a ligands
Inventor: CLIFFE IAN ANTHONY
IPC: A61K31/44
Filed: 1994-03-09
Abstract: PCT No. PCT/GB94/00455 Sec. 371 Date May 25, 1995 Sec. 102(e) Date May 25, 1995 PCT Filed Mar. 9, 1994 PCT Pub. No. WO94/21611 PCT Pub. Date Sep. 29, 1994Amide Derivatives of formula (I) wherein R1 is a mono or bicyclic heteroaryl radical, R2 is cycloalkyl, R3 and R4 each represent hydrogen or lower alkyl, and R5 is a group of formula (A) or (B) or (C): R8-CH2-CH2- or (D) or (E): R9OCH2CHOHCH2- or (F): R9OCH2CH2- and their pharmaceutically acceptable salts are 5-HT1A binding agents and may be used, for example, as anxiolytics.    <IMAGE>  (I)
Patent AU-6368199-A (AU)
Title: Polyester resin composition and fiber
Inventor: KATO JINICHIRO
IPC: D01F1/10
Filed: 1999-10-29
Abstract: A polyester resin composition containing, as a resin component, a polyester with its main component formed from a polytrimethylene terephthalate and having an intrinsic viscosity of 0.4 to 2, which satisfies the following conditions (1) to (3):   (1) the polyester resin composition is composed of a polyester resin component comprising 90% by weight or more of a polytrimethylene terephthalate; (2) the polyester resin composition contains 0.01 to 3% by weight of titanium oxide having an average particle size from 0.01 to 2  mu m; and (3) the polyester resin composition contains 25 or less/mg of the resin of agglomerates of titanium oxide particles which agglomerates have a lengthwise size exceeding 5  mu m.   A polytrimethylene terephthalate-based polyester fiber, having a low frictional coefficient, excellent in wear resistance, and showing a suitable luster and a delustered effect, can be stably spun and drawn by applying a melt spinning method to the polyester resin composition. In addition, the resin composition is prepared by forming a 1,3-propanediol ester of terephthalic acid and/or its oligomer in the presence of a fine dispersion of titanium oxide in which the dispersion the agglomerates is controlled and subjecting the ester and/or its oligomer to a polycondensation reaction.